Abstract
Recently, umbilical cord blood has been used in the treatment of various ocular surface diseases in ophthalmology. Umbilical cord blood contains essential tear components, growth factors, and neurotrophic factors such as epidermal growth factor, vitamin A, transforming growth factor-b, substance P, insulin-like growth factor, and nerve growth factor. Umbilical cord serum can provide basic nutrients for epithelial renewal and facilitate the proliferation, migration, and differentiation of the ocular surface epithelium. Serum eye drops made from umbilical cord blood can be used safely and effectively for the treatment of severe dry eye with or without Sjögren’s syndrome, ocular complications in graft-versus-host disease, persistent epithelial defects, and neurotrophic keratopathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Esquenazi S, He J, Bazab HEP, Bazan NG. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea. 2005;24:992-997.
Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000;40:113-122.
Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.
Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol. 1999;83:390-395.
Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatrical pemphigoid and Steven-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.
Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eyedrops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583.
Noble BA, Loh RS, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88:647-652.
Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol. 2005;139:242-246.
Tananuvat N, Daniell M, Suillivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20:802-806.
Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent epithelial defect by autologous serum application. Ophthalmology. 1999;106:1984-1989.
Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.
Young AL, Cheng AC, Ng HK, et al. The use of autologous serum tears in persistent epithelial defect. Eye. 2004;18:609-614.
Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115-1120.
Banker AS, Freeman WR, Azen SP, et al. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Arch Ophthalmol. 1999;117:1499-1502.
Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20:807-810.
del Castillo JM, de la Casa JM, Sardina RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21:781-783.
Schulze S, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142:207-211.
Matsuo H, Tomidokoro A, Tomita G, Araie M. Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye. 2005;19:23-28.
Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87:1312-1316.
Yoon KC, Heo H, Jeong IY, Park YG. Therapeutic effect of umbilical cord serum eydrops for persistent corneal epithelial defect. Korean J Ophthalmol. 2005;19:174-178.
Yoon KC, Im SK, Park YG, et al. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006;25:268-272.
Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant. 2007;39:231-235.
Yoon KC, You IC, Im SK, et al. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. 2007;114:1637-1642.
Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144:86-92.
Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467-1474.
Speek AJ, van Agtmaal EJ, Saowakontha S, et al. Fluorometric determination of retinol in human tear fluid using high-performance liquid chromatography. Curr Eye Res. 1986;5:841-845.
Ohashi Y, Motokura M, Kinoshita Y, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989;30:1879-1882.
Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol. 2005;243:706-714.
Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1 [letter]. Arch Ophthalmol. 1997;115:926-927.
Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I [letter]. Lancet. 1998;351:1783-1784.
Tan MH, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea. 2006;25:352-355.
Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. New Eng J Med. 1998;338:1174-1180.
Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2006;38:223-227.
Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235-242.
Choong PF, Mok PL, Cheong SK, Then KY. Mesenchymal stem cell-like characteristics of corneal keratocytes. Cytotherapy. 2007;9:252-258.
Kioke-Kiriyama N, Adachi Y, Minamino K, et al. Human cord blood cells can differentiate into retinal nerve cells. Acta Neurobiol Exp (Wars). 2007;67:359-365.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Yoon, KC. (2011). Umbilical Cord and Its Blood: A Perspective on Its Current and Potential Use in Ophthalmology. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-84882-718-9_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-717-2
Online ISBN: 978-1-84882-718-9
eBook Packages: MedicineMedicine (R0)